Sign in
Taking people in United StatesNo phase

Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

Key facts

Who runs it
Children's Hospital of Philadelphia
Where
Atlanta, Austin, Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Dallas, Denver, Indianapolis, Iowa City, Milwaukee, New Hyde Park, New York, Orange, Philadelphia, Richmond, Seattle, St Louis, Stanford, and Wilmington, United StatesSee the 22 sites
Trial code
Status
Recruiting
People taking part
1,620 people, planned
Started
1 Jul 2024
Expected to end
30 Jun 2029
Type of study
Observational
Record updated
17 November 2026

Who can take part

Age
37 weeks to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Arrest in an ICU
  • Patients received chest compressions for at least 1 minute

Who cannot take part

  • Lack of commitment to aggressive therapies (e.g., CPR performed as part of end-of-life care)
  • Brain death determination prior to CPR
  • Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes)
  • Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR

This trial is currently available in United States.

  • Children's Healthcare of AtlantaAtlanta, United StatesContact: Stephanie BrownTaking people
  • Dell Children's Medical CenterAustin, United StatesContact: Hunter DaigleTaking people
  • Boston Children's HospitalBoston, United StatesContact: Catherine RossTaking people
  • UNC Children's HospitalChapel Hill, United StatesContact: Afsaneh PirzadehTaking people
  • Comer Children's HospitalChicago, United StatesContact: Priti JaniTaking people
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Daniel LoebTaking people
  • Nationwide Children's HospitalColumbus, United StatesContact: John JenningsTaking people
  • Medical City Children's HospitalDallas, United StatesContact: Tia RaymondTaking people
  • University of Texas Southwestern Medical CenterDallas, United StatesContact: Javier LasaTaking people
  • Children's Hospital ColoradoDenver, United StatesContact: Carly ScahillTaking people
  • Riley Children's HealthIndianapolis, United StatesContact: Maria FrazierTaking people
  • Stead Family Children's HospitalIowa City, United StatesContact: Sarah HaskellTaking people
  • Children's WisconsinMilwaukee, United StatesContact: Andrea MaxwellTaking people
  • Cohen Children's Medical CenterNew Hyde Park, United StatesContact: Todd SwebergTaking people
  • Columbia University Irving Medical CenterNew York, United StatesContact: Anita SenTaking people
  • CHOCOrange, United StatesContact: Jennifer HayesTaking people
  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Ryan MorganTaking people
  • Children's Hospital of Richmond at VCURichmond, United StatesContact: Michelle OlsonTaking people
  • Seattle Children'sSeattle, United StatesContact: Joan RobertsTaking people
  • Washington University in St. LouisSt Louis, United StatesContact: Ashley TurnerTaking people
  • Stanford Medicine Children's HealthStanford, United StatesContact: Felice SuTaking people
  • Nemours Children's HealthWilmington, United StatesContact: Yosef LevenbrownTaking people

About the trial

What the trial wants to find out

This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of this study is to evaluate the physiologic response to epinephrine as an outcome discriminator in pediatric in-hospital cardiac arrest (IHCA). In addition, the investigators will determine optimal epinephrine dosing strategies based on the initial physiologic response to epinephrine, and to develop machine learning (ML) algorithms to guide intra-arrest therapy.

The group in the trial

  • Pediatric Cardiac Arrests

    Pediatric cardiac arrests requiring chest compressions for at least 1 minute occurring in an ICU identified as part of standard clinical operations.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 November 2026